Midazolam (Versed) and Fentanyl Both Lower Intraocular Pressure
Midazolam moderately lowers intraocular pressure, and when combined with fentanyl for anesthesia induction, this IOP-lowering effect is maintained or enhanced. 1, 2
Key Evidence on IOP Effects
Midazolam's Effect on IOP
The FDA label for Versed explicitly states: "Measurements of intraocular pressure in patients without eye disease show a moderate lowering following induction with midazolam" 1. This is a documented pharmacologic effect of the drug.
Clinical research confirms this effect:
- In a randomized controlled trial, midazolam (0.15 mg/kg) reduced IOP to 57% of pre-induction values when combined with fentanyl for cataract surgery 2
- A prospective randomized trial in adults found midazolam did not significantly alter IOP from baseline, suggesting a neutral to mildly beneficial effect 3
- Animal studies consistently demonstrate IOP reduction with midazolam-containing anesthetic protocols 4, 5
Fentanyl's Effect on IOP
Fentanyl appears to have minimal direct effect on IOP:
- In conscious dogs, fentanyl infusion caused no significant IOP changes 6
- When combined with midazolam, the IOP-lowering effect is preserved 2
Combined Effect
The combination of midazolam and fentanyl is suitable for intraocular surgery because it maintains or enhances IOP reduction 2, 7. The synergistic sedative effects do not counteract the beneficial IOP-lowering properties.
Critical Contraindication
Midazolam is absolutely contraindicated in acute narrow-angle glaucoma 1. However, it may be used in open-angle glaucoma patients receiving appropriate therapy, as the drug actually lowers IOP rather than raising it.
Clinical Application
For procedures requiring IOP control:
- Midazolam provides moderate IOP reduction
- Adding fentanyl maintains this benefit while providing analgesia
- The combination is particularly useful for cataract surgery and other intraocular procedures 2, 7
Important caveat: In neonates, the combination requires careful administration—rapid IV fentanyl in patients receiving midazolam infusion (or vice versa) has caused severe hypotension 1. Use slow administration techniques in this population.